MedNet Solutions Announces Key Enhancements to EMPOWER, Its Investigator Initiated-Sponsored Research Management Solution
MedNet Solutions is pleased to announce significant enhancements to EMPOWER™, the company’s investigator initiated ‐ sponsored research (IISR) management solution. The EMPOWER system is currently being utilized by pharmaceutical and medical device companies to automate and streamline investigator research submissions, management and reporting.
The EMPOWER enhancements, which are being rolled out in three separate releases during the third quarter of 2010, have been designed to: 1) increase the standard functionality available in each of the system’s core modules, 2) expand the inherent configurability of the system to meet each customer’s requirements, 3) add new standard reports and metrics that allow customers to continually improve their overall IISR management program.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
